Wolfe Research Initiates Coverage On Krystal Biotech with Peer Perform Rating

Benzinga Newsdesk www.benzinga.com Positive 74.1%

Neg 0% Neu 0% Pos 74.1%

Wolfe Research analyst Kalpit Patel initiates coverage on Krystal Biotech (NASDAQ:KRYS) with a Peer Perform rating.

Comments

No comments yet. Be the first!